Luthra And Luthra Advised Orchid Pharma With Its QIP Worth INR 400 Crores

The Firm’s Capital Markets team advised Orchid Pharma Limited, a Tamil Nadu based pharmaceutical manufacturing company, in connection with its qualified institutions placement of 9,902,705 equity shares aggregating to ₹400 crore. The lead managers to this QIP were Edelweiss Financial Services Limited and JM Financial Limited.The transaction team...